Epiphany Biosciences, Inc.

Pharmaceuticals Aegerion Pharmaceuticals Inc. Aegerion gets $15mm through debt placement March — Aegerion Pharmaceuticals (therapeutics for cardiovascular and metabolic diseases) has raised $15mm wi

In Vitro Diagnostics Asuragen Inc. Yale University Asuragen licenses oncogene rights from Yale Jan. — Asuragen (molecular diagnostics and therapeutics for cancer) has licensed from Yale University

In Vitro Diagnostics Acquisitions Cytyc Corp. Vision Systems Ltd. Challenging a bid from Ventana Medical Systems , Cytyc (diagnostics and devices for cancer and women's health) intends to offer $A4